Abstract
BackgroundAlthough recent development of a variety of biologics has dramatically improved treatment for rheumatoid arthritis (RA), it is still unclear which biologics is better for use in each patient. Some...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
